Andrea Goldyn, MD

Senior Director-Diabetes Global Medical Affairs
Eli Lilly and Company

Andrea Goldyn, MD is a Senior Director in Diabetes Global Medical Affairs at Eli Lilly and Company and a pediatric endocrinologist.

Poster(s):

• (P112) Once-Weekly Basal Insulin Efsitora Alfa Demonstrates Similar Glycemic Control to Once-Daily Insulin Degludec in Insulin-Naive Patients With T2D: Results from Phase 2
  Saturday, August 10, 2024

  12:15 PM – 1:15 PM CT